Ilaria Plantamura - Concepedia

Author

Ilaria Plantamura

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID

Also Known As

I Plantamura, I. Plantamura, Ilaria Plantamura

Publications

927

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori National Institute of Genomic Medicine Zero to Three Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán University of Milan

About

Ilaria Plantamura is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in cancer research, tumor biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	206
2	Cell Biology	4	4	206
3	Cancer Cell Biology	3	3	165
4	Pathology	2	2	68
5	Engineering	1	1	27

Ilaria Plantamura

Publications

729

Citations

H-Index

Page 1

	Year	Citations
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts Sara Baroni, Sandra Romero‐Córdoba, Ilaria Plantamura, Cell Death and Disease	2016	297
Oncosuppressive role of p53‐induced miR‐205 in triple negative breast cancer Claudia Piovan, Dario Palmieri, Gianpiero Di Leva, Molecular Oncology	2012	162
miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer Elvira D’Ippolito, Ilaria Plantamura, Lucia Bongiovanni, Cancer Research Breast OncologyNanotherapeuticsTumor CellsCancer BiologyPdgfrβ Expression	2016	97
PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells Ilaria Plantamura, Patrizia Casalini, Erica Dugnani, Molecular Oncology Breast OncologyImmunotherapeuticsTnbc CellsCancer BiologyTumor Biology	2014	41
CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers Federica Turdo, Francesca Bianchi, Patrizia Gasparini, Oncotarget Breast OncologyCdcp1 PositivityNovel MarkerMedicineCdcp1 Copy Number	2016	41
Abstract A47: A microRNA signature identifies subtypes of triple-negative breast cancer and reveals miR-342-3p as regulator of a lactate metabolic pathway through silencing monocarboxylate transporter 1 Sandra Romero‐Córdoba, Sergio Rodrı́guez-Cuevas, Rosa Rebollar-Vega, Cancer Research Mirna SubgroupsBreast OncologyEngineeringPathologyCancer Biology	2016	27
miR-9-Mediated Inhibition of EFEMP1 Contributes to the Acquisition of Pro-Tumoral Properties in Normal Fibroblasts Giulia Cosentino, Sandra Romero‐Córdoba, Ilaria Plantamura, Cells	2020	20
MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer Alessandra Cataldo, Sandra Romero‐Córdoba, Ilaria Plantamura, Cancers	2020	18
MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab Alessandra Cataldo, Claudia Piovan, Ilaria Plantamura, Oncotarget	2018	16
What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study Sara Pizzamiglio, Giulia Cosentino, Chiara Maura Ciniselli, Cancer Medicine	2021	10

Page 1